Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy

Since the first report of an association between cardiac troponin (cTn) and adverse outcome in hypertrophic cardiomyopathy (HD), there is a paucity in confirmative data. We performed a prospective, prespecified 5-year follow-up cohort study of 135 HC patients who participated in a national multicenter project and underwent clinical evaluation, MRI (cine, LGE and T2-weighted imaging) and biomarker assessment (high-sensitivity cTnT (hs-cTnT), N-terminal pro-B-type natriuretic peptide, soluble tumorgenicity suppressor-2, Galectin-3, Growth differentiation factor-15, C-terminal Propeptide of Type I Collagen (CICP)).

Source: The American Journal of Cardiology - June 12, 2021 Category: Cardiology Authors: D.H. Frank Gommans, G. Etienne Cramer, Michael A. Fouraux, Sanne Heijmans, Michelle Michels, Janneke Timmermans, Freek W.A. Verheugt, Rudolf A. de Boer, Marcel J.M. Kofflard, Marc A. Brouwer Source Type: research